←Back to Expert Scholars
Translational Medicine / 转化医学Antiemetics, Nausea Management Cancer
Lara Dunn
MD
🏢Memorial Sloan Kettering Cancer Center🌐USA
Medical Oncologist
32
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Lara Dunn at MSK has contributed to antiemetic clinical research and CINV (chemotherapy-induced nausea and vomiting) management guidelines. Her work on novel antiemetic agents and optimal antiemetic regimen combinations for different emetogenic chemotherapy risk categories contributes to supportive care excellence in oncology.
Share:
🧪Research Fields 研究领域
chemotherapy-induced nausea
antiemetic regimens
CINV management
NK1 receptor antagonists
nausea cancer clinical trials
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Lara Dunn 的研究动态
Follow Lara Dunn's research updates
留下邮箱，当我们发布与 Lara Dunn（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment